Clinilabs, Inc. Release: Dr. Gary Zammit to Present On the Safety and Efficacy of Hypnotic Drugs

York, NY (May 9, 2011) – Clinilabs, a full-service contract research organization that provides early-phase and specialty clinical drug development services to industry, announced today that President and CEO, Dr. Gary Zammit, will participate as a speaker and discussant in an FDA-PERI co-sponsored workshop on the safety and efficacy of hypnotic drugs.

The interactive program will include presentations and panel discussions by academic experts, leading researchers, key opinion leaders, and regulators in the field of hypnotic drugs and sleep disorders. Topics will include the definition of insomnia, study population selections, endpoints and efficacy assessments. The two-day workshop will be held May 10-11, 2011 in Bethesda, MD. The complete seminar may be viewed live at www.fdalive.com for a nominal fee, and a DVD recording will also be available for purchase following the event. Dr. Zammit, who will be speaking on the safety of hypnotic drugs in relation to primary pharmacodynamic effects, states: “It is both a pleasure and a privilege to take part in this forum. This discussion promises to be informative and interactive, and will address key topics related to therapeutics for insomnia.” Zammit notes that insomnia is a significant health concern that is associated with significant morbidy, making it critically important for those in the field to keep abreast of current thinking regarding the efficacy and safety of drug treatment.

About Clinilabs Inc.

Clinilabs is a full-service contract research organization (CRO) that provides early-phase and specialty clinical drug development services to industry. One of the Company’s primary specialties is the development of therapeutic drugs and devices for sleep disorders. Clinilabs is recognized globally as a leading CRO in the field of sleep medicine, and has made important contributions to eleven successful new drug applications (NDAs) since 2001, For more information, please visit www.clinilabs.com.

For more information or to schedule an interview, please contact Hannah D’Aoust at 646.215.6411 or e-mail hdaoust@clinilabs.com